Artiva Biotherapeutics, Inc. (ARTV) Operating cash flow 2023–2025
Artiva Biotherapeutics, Inc. (ARTV) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$76.8MFY2025 · since FY2023: -$47.4M → -$76.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$76.8M | -39.5% |
| FY2024 | -$55.0M | -16.0% |
| FY2023 | -$47.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice